Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease.
Katarzyna Muras-SzwedziakEwa PawłowiczMichal NowickiPublished in: Renal failure (2023)
Although intravenous iron therapy causes parallel increase of FGF-23 and supression of endogenous EPO, these two effects seem to be independent.